nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Access to diabetes technology: the role of clinician attitudes
|
Farrington, Conor |
|
2018 |
6 |
1 |
p. 15 |
artikel |
2 |
Aiding sleep in type 2 diabetes: therapeutic considerations
|
Tan, Xiao |
|
2018 |
6 |
1 |
p. 60-68 |
artikel |
3 |
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
|
Hundemer, Gregory L |
|
2018 |
6 |
1 |
p. 51-59 |
artikel |
4 |
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis
|
Monticone, Silvia |
|
2018 |
6 |
1 |
p. 41-50 |
artikel |
5 |
Correction to Lancet Diabetes Endocrinol 2018; 6: 17–26
|
|
|
2018 |
6 |
1 |
p. e1 |
artikel |
6 |
Diabetes: mapping the titanic struggle ahead
|
The Lancet Diabetes & Endocrinology, |
|
2018 |
6 |
1 |
p. 1 |
artikel |
7 |
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
|
Lacroix, André |
|
2018 |
6 |
1 |
p. 17-26 |
artikel |
8 |
Iodine supplementation in pregnant women and child neurodevelopment
|
Mao, Song |
|
2018 |
6 |
1 |
p. 10 |
artikel |
9 |
Iodine supplementation in pregnant women and child neurodevelopment – Author's reply
|
Zimmermann, Michael B |
|
2018 |
6 |
1 |
p. 10 |
artikel |
10 |
Is the new treatment for Cushing's disease too sweet?
|
Grossman, Ashley |
|
2018 |
6 |
1 |
p. 2-3 |
artikel |
11 |
Linoleic acid and diabetes prevention
|
Henderson, George |
|
2018 |
6 |
1 |
p. 12-13 |
artikel |
12 |
Linoleic acid and diabetes prevention – Authors' reply
|
Wu, Jason H Y |
|
2018 |
6 |
1 |
p. 13 |
artikel |
13 |
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial
|
Parvanova, Aneliya |
|
2018 |
6 |
1 |
p. 27-40 |
artikel |
14 |
Paricalcitol and albuminuria: tread carefully
|
Fernandez-Fernandez, Beatriz |
|
2018 |
6 |
1 |
p. 3-5 |
artikel |
15 |
Primary aldosteronism and cardiovascular risk, before and after treatment
|
Funder, John W |
|
2018 |
6 |
1 |
p. 5-7 |
artikel |
16 |
Questioning the safety and benefits of evolocumab
|
Mascitelli, Luca |
|
2018 |
6 |
1 |
p. 11 |
artikel |
17 |
Questioning the safety and benefits of evolocumab – Authors' reply
|
Sabatine, Marc S |
|
2018 |
6 |
1 |
p. 11-12 |
artikel |
18 |
Research in brief
|
Kang, Seema |
|
2018 |
6 |
1 |
p. 14 |
artikel |
19 |
Sugar: the prime suspect in poor health
|
Burki, Talha Khan |
|
2018 |
6 |
1 |
p. 16 |
artikel |
20 |
Type 2 diabetes in adolescents and young adults
|
Lascar, Nadia |
|
2018 |
6 |
1 |
p. 69-80 |
artikel |
21 |
What research is needed to address the co-epidemics of HIV and cardiometabolic disease in sub-Saharan Africa?
|
Geldsetzer, Pascal |
|
2018 |
6 |
1 |
p. 7-9 |
artikel |